The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy-Reference-Cited by-同舟云学术

The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy

Published:2023-07 Issue: Volume:120 Page:110329
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Chen Yunhao,Ding Xingchen,Bai Xinbin,Zhou Zihan,Liu Yu,Zhang Xianbin,Yu Jinming,Hu Man^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference65 articles.

1. Progress and challenges of immunotherapy in triple-negative breast cancer;Zhu;Biochim Biophys Acta Rev Cancer.,2021

2. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma;Lyford-Pike;Cancer Res.,2013

3. Detection of distant metastases in head and neck cancer: changing landscape;de Bree;Adv Ther.,2018

4. Head and neck cancer survivorship care guideline: American Society of Clinical Oncology clinical practice guideline endorsement of the American Cancer Society guideline;Nekhlyudov;J Clin Oncol.,2017

5. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage;Hira-Miyazawa;Int J Oncol.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and molecular insights in oral squamous cell carcinoma therapy - Advancing the horizon;Oral Oncology Reports;2024-09

2. Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-04-08

3. Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma;The Journal of Pathology: Clinical Research;2024-01-17

4. PD-1 inhibitors combined with chemotherapy versus chemotherapy alone: efficacy and prognostic analysis in recurrent metastatic nasopharyngeal carcinoma;American Journal of Translational Research;2024

5. Programmed Cell Death Ligand 1 Immunoexpression in Head and Neck Squamous Cell Carcinoma: A Narrative Review of Considerations for the Histopathologist;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024